Location of Repository

N-terminal pro B type natriuretic peptide is better than TIMI risk score at predicting death following acute myocardial infarction

By S.Q. Khan, P. Quinn, J.E. Davies and L.L. Ng

Abstract

This is the authors' final draft of the paper published as Heart, 2008, vol 94 (1), pp.40-43. The final published version is available at http://heart.bmj.com/cgi/content/full/94/1/40?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&volume=94&firstpage=40&resourcetype=HWCI

Publisher: BMJ Publishing Group Ltd
Year: 2008
OAI identifier: oai:lra.le.ac.uk:2381/3519

Suggested articles

Preview

Citations

  1. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. doi
  2. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction. doi
  3. Plasma brain natriuretic peptide predicts survival after acute myocardial infarction. doi
  4. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.